| IKBKE is a breast cancer oncogene | breast, |
| Integrative genomic approaches identify IKBKE as a breast cancer oncogene. | breast, |
| Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation. | breast, |
| IkappaB-Kinase-epsilon (IKKepsilon/IKKi/IkappaBKepsilon) expression and localization in prostate cancer tissues. | prostate, |
| This study strongly suggests the role of IKKepsilon as a prostate cancer oncogene that may be involved in the emergence of a castrate-resistent state. | prostate, |
| IKKepsilon is overexpressed in many breast cancers and phosphorylates numerous targets involved in new oncogenic signaling pathways. It is involved in tamoxifen resistance. Review. | breast, |
| Increased expression of estrogen receptor alpha-36 by breast cancer oncogene IKKepsilon promotes growth of ER-negative breast cancer cells. | breast, |
| Blunting of NOX2-dependent IKKepsilon oncogenic kinase expression reduces proliferation and viability of human breast cancer cells. | breast, |
| Results suggest that IKKepsilon and CYLD function as an oncogene-tumor suppressor network that participates in tumorigenesis. | None |